新医改或将有望改变医药工、商企业的博弈,最终缓解“看病贵”的问题。作为新医改的源头,药厂认为,此次医改主要解决的是“看病难、看病贵”问题,医院是理所当然的被“医改”的重点。而对于“看病贵”的问题,药厂大喊不公,在他们看来,药企利润最薄,药价贵是政府对医疗投入不足、实行以 The new medical reform or will be expected to change the game of pharmaceutical workers, business enterprises, and ultimately alleviate the “expensive” problem. As the source of new medical reform, pharmaceutical companies believe that the medical reform is mainly to solve the problem of “difficult to see a doctor, expensive to see a doctor,” and the hospital is taken for granted as the focus of “medical reform.” As for the problem of expensive medical treatment, the pharmaceutical factory shouts injustice. In their view, the profit of the pharmaceutical enterprise is the thinnest and the price of medicine is the government’s insufficient investment in medical treatment.